TheraRadar

Pharma Intelligence, Simplified

Landscape → Infectious Disease

H. pylori

157 clinical trials

52 active
/
157 total (since 2015)
2
Phase 1 Active
16 total
9
Phase 2 Active
18 total
11
Phase 3 Active
33 total
34
Phase 4 Active
99 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
ARJ Medical, Inc. 2 1 0
Catalysis SL 1 0 0
TenNor Therapeutics (Suzhou) Limited 0 6 0
Takeda 0 3 0
HK inno.N Corporation 0 3 0
NCT07275827 NOT YET RECRUITING
Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection
Tanta University n=88
NCT07104318 NOT YET RECRUITING
Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans
VA Office of Research and Development n=360
NCT06734260 RECRUITING
Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection
Eighth Affiliated Hospital, Sun Yat-sen University n=477
NCT07246681 ACTIVE NOT RECRUITING
Lignin in Treatment of Helicobacter Pylori Infection
Zagazig University n=70
NCT07242456 RECRUITING
Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication
First People's Hospital of Hangzhou n=240
NCT06964334 NOT YET RECRUITING
The Effect of Vitamin D Supplement as Adjuvant Therapy in Eradication of Helicobacter Pylori Infection
Assiut University n=70
NCT06760065 NOT YET RECRUITING
Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment
Sixth Affiliated Hospital, Sun Yat-sen University n=316
NCT06591494 NOT YET RECRUITING
The Efficacy of Quadruple Therapy Containing Sodium Bicarbonate as the Primary Treatment for Helicobacter Pylori Infection
Second Affiliated Hospital, School of Medicine, Zhejiang University n=855
NCT05681689 RECRUITING
PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study
ARJ Medical, Inc. n=77
NCT05276557 RECRUITING
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
ARJ Medical, Inc. n=40
NCT04415983 RECRUITING
Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children
Tanta University n=100
NCT06340724 COMPLETED
Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication
Nanjing First Hospital, Nanjing Medical University n=104
NCT06751121 COMPLETED
Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
Daewoong Pharmaceutical Co. LTD. n=461
NCT06576882 COMPLETED
7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication
Alexandria University n=326
NCT06414707 COMPLETED
Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori
Ain Shams University n=320
NCT04473079 COMPLETED
Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia
Lallemand Health Solutions n=90
NCT05297695 COMPLETED
Helicobacter Pylori Eradication Therapy for Epileptic Children
Sohag University n=126
NCT05577468 COMPLETED
Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. n=561
NCT05719831 COMPLETED
Optimization of Vonoprazan--amoxicillin Dual Therapy for Eradicating Helicobacter Pyloriinfection
Sixth Affiliated Hospital, Sun Yat-sen University n=516
NCT03779074 COMPLETED
Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies
Kaohsiung Veterans General Hospital. n=918
NCT06101420 COMPLETED
Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication
Ain Shams University n=232
NCT04198363 COMPLETED
A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection
Takeda n=510
NCT05863858 COMPLETED
Eradication of H. Pylori Infection With Moxifloxacin
Iyad Naeem Muhammad, PhD n=162
NCT05861687 COMPLETED
Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children
Finni Kollins n=51
NCT02528721 COMPLETED
Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection
Meridian Bioscience, Inc. n=282
NCT02905825 COMPLETED
Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics
Meridian Bioscience, Inc. n=54
NCT04167670 COMPLETED
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection
Phathom Pharmaceuticals, Inc. n=1,046
NCT03317223 COMPLETED
A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients
HK inno.N Corporation n=350
NCT04128917 COMPLETED
Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT
HK inno.N Corporation n=102
NCT03498456 COMPLETED
Triple Therapy With Tegoprazan in H. Pylori Positive Patients
HK inno.N Corporation n=284
NCT02557932 COMPLETED
Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
National Cancer Center, Korea n=352
NCT03198507 COMPLETED
ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator
RedHill Biopharma Limited n=455
NCT02827942 COMPLETED
Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
Hamamatsu University n=112

Data: ClinicalTrials.gov